InnovAge Holding (INNV) stock
Market cap $1.2B
Market closed. Prices as of Friday's close.
Members see every stock ranked and every check behind each score, live.
Why it's down
Fell 16% on Sep 23.
Down more than its industry: the 6 other stocks in it fell a median 3% that day.
−2News Dilutive offering
What's next
Expected to report Tue Nov 3, after the close
After its last 4 reports it closed +6.7% on average, higher 3 of 4 times.
What would move INNV's score: 6 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.
INNV has 3 of a possible 13 checks firing
14 checks. Two are opposites (heavy volume and quiet volume), so at most 13 are on at once. One per group is shown here.
How INNV ranks in Services-Health Services
INNV is #5 of 7 by Quality Score. The top three are shown with their scores, and the rest by name.
- 1
PNTGThe Pennant Group7/1317
- 2
LFSTLifeStance Health Group1/1310
- 5
INNVInnovAge Holding3/136
WGSGeneDx HoldingsOpen for its score
When does INNV report, and what happens after?
Expected to report Tue Nov 3, after the close (in 37 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Sep 8, 2026After close | After close | +11.2% | +4.8% | +3.8% |
| May 5, 2026After close | After close | -3.9% | +2.0% | -5.2% |
| Feb 3, 2026After close | After close | +14.8% | +37.5% | +47.9% |
| Nov 4, 2025After close | After close | +0.1% | -17.6% | +12.0% |
The gap is the next open against the close before the report; the reaction is where that session closed. INNV closed higher after 3 of its last 4. Past behavior, not a forecast.
Report dates and past reactions come from sessions that have already closed, so none of these figures move.
About InnovAge Holding
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. It manages its business as one reportable segment, PACE.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of INNV's score, with the points and the reason
- All 14 checks on INNV and on all 2,950 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on INNV
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits rest on real history. Options flow is not part of the product.
What does it cost?
One plan with everything in it: $29 a month, $69 for three months, or $249 a year. You pick the billing period when the trial ends, and payments go through Stripe, so Breakaway never sees your card.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.
The price, the score, the traits, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.